| Section 1.31 - Disclosure of confidential cancer information |
|
| Section 2.59 - Prevention of influenza transmission by healthcare and residential facility and agency personnel |
|
| Section 12.3 - Precautions to be observed for the prevention of hemorrhagic diseases and coagulation disorders of the newborn and infants related to vitamin K deficiency |
|
| Section 12.10 - Precautions to be observed in the use of dyes and inks containing aniline or nitrobenzene or other benzene derivatives for marking diapers and hospital linens |
|
| Section 12.12 - Warning label required on certain plastic material |
|
| Section 16.1 - Applicability and inapplicability of this Part |
|
| Section 16.2 - Definitions |
|
| Section 16.24 - Quality assurance programs for the use of radiation for therapy in humans |
|
| Section 16.100 - Licensing requirements for use of radioactive materials |
|
| Section 16.120 - Specific licenses for the use of radioactive materials on human beings |
|
| Section 16.123 - Specific licenses for certain medical uses of byproduct materials |
|
| Appendix 16 - Tables |
|
| Appendix 16 - A(1) and A(2) Values for Radionuclides |
|
| Appendix 16 - Annual Limits on Intake and Derived Air Concentrations of Radionuclides for Occupational Exposure Effluent Concentrations |
|
| Part 35 - Vital Records |
|